Shares of NexImmune, Inc. (NASDAQ:NEXI – Get Free Report) traded up 0.1% during mid-day trading on Wednesday . The company traded as high as $0.10 and last traded at $0.10. 147 shares were traded during mid-day trading, a decline of 99% from the average session volume of 17,332 shares. The stock had previously closed at $0.10.
NexImmune Stock Performance
The business’s 50 day simple moving average is $0.20 and its 200-day simple moving average is $0.49. The company has a market cap of $139,139.00, a price-to-earnings ratio of -0.01 and a beta of 1.91.
About NexImmune
NexImmune, Inc, a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform.
Featured Articles
- Five stocks we like better than NexImmune
- Stock Average Calculator
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- How to Choose Top Rated Stocks
- 3 Steel Stocks Soaring After Tariff Announcements
- What is Short Interest? How to Use It
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for NexImmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexImmune and related companies with MarketBeat.com's FREE daily email newsletter.
